Research · head to head
DNAnexus vs Genedata
DNAnexus
Research
Regulated cloud platform for genomic and multiomic data, with GxP and FedRAMP coverage
- From
- On request
- Rated
- -
Genedata
Research
Enterprise R&D data platforms for biologics, screening and bioprocess, owned by Danaher
- From
- On request
- Rated
- -
The short version
- Each has a real cost: DNAnexus no pricing is published, so an organisation cannot compare the total cost against running the same pipelines on its own cloud account until it is deep in a sales process.; Genedata there is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
- They diverge on capability: DNAnexus covers Governed data storage, Genedata covers Screener.
- Prices and features above were last checked on 31 August 2026.
Where they differ
Only the attributes on which DNAnexus and Genedata actually diverge.
Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Research).
What each one covers
Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.
Only in DNAnexus
- Governed data storage
- Workflow execution
- App building
- Controlled collaboration
- Compliance posture
- Cohort browsing
Only in Genedata
- Screener
- Biologics
- Bioprocess
- Expressionist
- Selector
- Profiler
- Instrument integration
- GxP-capable deployments
What people use each for
The jobs each tool is most often brought in to do.
DNAnexus
- A clinical diagnostics laboratory that needs a CLIA and CAP aligned environment for production sequencing pipelines without building the compliance evidence itselfnot Genedata
- A pharma sponsor analysing genomic endpoints in a registrational programme where 21 CFR Part 11 records are requirednot Genedata
- A biobank or consortium giving hundreds of external researchers governed access to a dataset too large to distributenot Genedata
- A diagnostics vendor packaging its pipeline as a versioned app so partner laboratories can run it without receiving the source codenot Genedata
Genedata
- A pharmaceutical screening group processing thousands of plates a week where manual QC and curve fitting no longer scalenot DNAnexus
- A biologics discovery team linking antibody sequence, expression and assay data across a campaign instead of in spreadsheetsnot DNAnexus
- A process development group standardising bioprocess run data across sites for modelling and scale-upnot DNAnexus
- A CRO delivering high-throughput screening results to sponsors that require documented, reproducible analysis pipelinesnot DNAnexus
Where each one falls short
Documented limitations, not opinions. Every one is a constraint you would hit in normal use.
DNAnexus
- No pricing is published, so an organisation cannot compare the total cost against running the same pipelines on its own cloud account until it is deep in a sales process.
- Compute and storage are billed through the platform rather than at underlying cloud list price, so the compliance envelope carries a persistent margin on every terabyte and core hour, which grows with the science rather than staying fixed.
- Data egress at genomic scale is slow and chargeable, so leaving the platform later is a real project rather than a contract decision, and that gravity weakens negotiating position at renewal.
- The regulated and validated configurations sit in a higher commercial tier than the research configuration, so an organisation that starts in research mode and later needs GxP faces a repricing rather than a setting change.
- Bioinformaticians used to running Nextflow on their own infrastructure find the platform abstractions constraining, and porting an existing pipeline into the app model is engineering work that does not carry over to any other platform.
Genedata
- There is no entry level and no published price at any tier, so a mid-sized biotech cannot even establish whether Genedata is in its range without a lengthy sales engagement.
- Platforms are licensed individually and most organisations need two or three, so the real contract is a sum of separate licences plus the integration work between them.
- Deployment is a services programme rather than an installation, running months and requiring scientific configuration by the vendor, which means value arrives long after the first invoice.
- Danaher ownership since 2023 gives the roadmap a natural pull toward Danaher instrument and bioprocessing lines, which is an advantage on that hardware and a question to ask if your instrument estate is from competitors.
- Validated deployments for regulated use add scope, cost and an ongoing revalidation obligation on your side after each vendor release, and that recurring internal effort is rarely counted in the business case.
Pricing, plan by plan
DNAnexus
On request- DNAnexus Platform$undefined/year
- Quoted per organisation through a sales process
- Storage and compute billed through the platform rather than at cloud list price
- Regulated and validated configurations are a separate commercial tier
Genedata
On request- Genedata platform licence$undefined/year
- Each platform, such as Screener or Biologics, licensed separately
- Annual enterprise subscription scoped on users, sites and data volume
- Implementation and scientific configuration services quoted as a separate programme
Which should you pick?
Choose DNAnexus if
- You need governed data storage.
- You work on Web, Linux.
- You also want workflow execution.
Choose Genedata if
- You need screener.
- You work on Web, On-premise, Private cloud.
- You also want biologics.
Questions people ask
- Is DNAnexus or Genedata better?
- Neither clearly leads. DNAnexus starts at On request and Genedata at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
- Which is cheaper, DNAnexus or Genedata?
- DNAnexus starts at On request and Genedata at On request.
- Does DNAnexus or Genedata run on more platforms?
- DNAnexus runs on Web, Linux. Genedata runs on Web, On-premise, Private cloud.
- What is DNAnexus best used for?
- DNAnexus is most often used for a clinical diagnostics laboratory that needs a clia and cap aligned environment for production sequencing pipelines without building the compliance evidence itself, a pharma sponsor analysing genomic endpoints in a registrational programme where 21 cfr part 11 records are required, a biobank or consortium giving hundreds of external researchers governed access to a dataset too large to distribute, a diagnostics vendor packaging its pipeline as a versioned app so partner laboratories can run it without receiving the source code. Of those, a clinical diagnostics laboratory that needs a clia and cap aligned environment for production sequencing pipelines without building the compliance evidence itself and a pharma sponsor analysing genomic endpoints in a registrational programme where 21 cfr part 11 records are required are not what Genedata is typically brought in for.
- What can DNAnexus do that Genedata cannot?
- DNAnexus covers Governed data storage, Workflow execution, App building, Controlled collaboration. Genedata covers Screener, Biologics, Bioprocess, Expressionist.
Answered from the vendors’ own pages
DNAnexus: Why pay for DNAnexus instead of raw AWS?
For the compliance evidence. GxP, FedRAMP, CLIA, CAP and Part 11 coverage removes a validation programme most organisations would otherwise have to build and maintain themselves.
Genedata: Who owns Genedata?
Danaher acquired the company in 2023. It remains headquartered in Basel and continues under the Genedata name.
DNAnexus: Is validated use included?
No. Regulated and validated configurations sit in a separate commercial tier from ordinary research use.
Genedata: Is there a small-team or starter option?
No. Everything is an enterprise contract scoped by users, sites and data volume, with services attached.
DNAnexus: Can I get my data out?
Yes, but egress at genomic scale is chargeable and slow, so plan exit costs at the point of signing.
Genedata: Do I buy one product or the whole suite?
Each platform is licensed separately. Most customers license two or three and integrate between them.
DNAnexus: Does it host UK Biobank?
Yes, DNAnexus hosts the UK Biobank research analysis platform, which has its own access approval and cost terms.
Genedata: Can it be used in a GxP environment?
Yes, with a validated deployment contracted as additional scope. Ongoing revalidation after releases remains your responsibility.
Related pages
Other head to heads
- DNAnexus vs Benchling
- DNAnexus vs Terra
- DNAnexus vs Seven Bridges
- DNAnexus vs Form Bio
- DNAnexus vs Labguru
- DNAnexus vs Dotmatics
- DNAnexus vs TetraScience
- DNAnexus vs Schrodinger
- DNAnexus vs LabWare
- DNAnexus vs STARLIMS
- DNAnexus vs Castor EDC
- DNAnexus vs Condens
- DNAnexus vs SurveySparrow
- DNAnexus vs Contentsquare
- DNAnexus vs LabArchives
- DNAnexus vs NVivo
- DNAnexus vs GWI
- DNAnexus vs Aurelius
- DNAnexus vs LabVantage
- DNAnexus vs Sapio Sciences
- DNAnexus vs Medidata Rave
- DNAnexus vs Suzy
- DNAnexus vs Chemaxon
- DNAnexus vs Thermo SampleManager LIMS
- DNAnexus vs Valispace
- DNAnexus vs Wolfram Mathematica
- Genedata vs Benchling
- Genedata vs Terra
- Genedata vs Seven Bridges
- Genedata vs Form Bio
- Genedata vs Labguru
- Genedata vs Dotmatics
- Genedata vs TetraScience
- Genedata vs Schrodinger
- Genedata vs LabWare
- Genedata vs STARLIMS
- Genedata vs Castor EDC
- Genedata vs Condens
- Genedata vs SurveySparrow
- Genedata vs Contentsquare
- Genedata vs LabArchives
- Genedata vs NVivo
- Genedata vs GWI
- Genedata vs Aurelius
- Genedata vs LabVantage
- Genedata vs Sapio Sciences
- Genedata vs Medidata Rave
- Genedata vs Suzy
- Genedata vs Chemaxon
- Genedata vs Thermo SampleManager LIMS
- Genedata vs Valispace
- Genedata vs Wolfram Mathematica